ESR1 and breast cancer: VPA treatment of MCF-7 breast cancer cells was associated with reduction of telomerase activity, increase in Bax/bcl-2 ratio [30], and decrease the expression of the invasiveness marker pS2 in ERα-positive breast cancer cells [31].